Cysteine cathepsin S processes leptin, inactivating its biological activity

Journal of Endocrinology

Volumn 214, Issue 2, 2012, Pages 217-224

  Oliveira, Marcela ^a   Assis, Diego M ^a   Paschoalin, Thaysa ^a   Miranda, Antonio ^a   Ribeiro, Eliane B ^a   Juliano, Maria A ^a   Brömme, Dieter ^b   Christoffolete, Marcelo Augusto ^c   Barros, Nilana M T ^a   Carmona, Adriana K ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; CYSTEINE PEPTIDASE; LEPTIN; MATRIGEL; PEPTIDASE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ANGIOGENESIS; ANIMAL TISSUE; APPETITE; ARTICLE; ATHEROSCLEROSIS; BONE DEVELOPMENT; CONTROLLED STUDY; DEGRADATION; ENDOTHELIUM CELL; ENERGY BALANCE; ENZYME MECHANISM; FOOD INTAKE; HORMONAL REGULATION; HYDROLYSIS; IMMUNE RESPONSE; INFLAMMATION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; AMINO ACID SEQUENCE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; CATALYTIC DOMAIN; CATHEPSINS; CELLS, CULTURED; CYSTEINE PROTEASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEPTIN; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

EID: 84866268294     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0108     Document Type: Article

References (56)

1. Anagnostoulis S, Karayiannakis AJ, Lambropoulou M, Efthimiadou A, Polychronidis A & Simopoulos C 2008 Human leptin induces angiogenesis in vivo. Cytokine 42 353-357
2. Arnlov J. 2012 Cathepsin S as a biomarker: where are we now and what are the future challenges? Biomarkers in Medicine 6 9-11
3. Attele AS, Shi ZQ & Yuan CS. 2002 Leptin, gut, and food intake. Biochemical Pharmacology 63 1579-1583
4. Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M & Hanada K. 1982 L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochemical Journal. 201 189-198.
5. Barrett GL, Trieu J & Naim T. 2009 The identification of leptin-derived peptides that are taken up by the brain. Regulatory Peptides 155 55-61.
6. Barrett GL, Naim T & Trieu J. 2011 Leptin-derived peptides that stimulate food intake and increase body weight following peripheral administration. Regulatory Peptides 170 24-30
7. Bertoni L, Ferretti M, Cavani F, Zavatti M, Resca E, Benelli A & Palumbo C. 2009 Leptin increases growth of primary ossification centers in fetal mice. Journal of Anatomy 215 577-583
8. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL et al.. 2005 Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54 2277-2286
9. Choe Y, Leonetti F, Greenbaum DC, Lecaille F, Bogyo M, Bromme D, Ellman JA & Craik CS. 2006 Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. Journal of Biological Chemistry 281 12824-12832.
10. Christoffolete MA, Ribeiro R, Singru P, Fekete C, da Silva WS, Gordon DF, Huang SA, Crescenzi A, Harney JW, Ridgway EC et al.. 2006 Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism. Endocrinology 147 1735-1743
11. Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martin-Romero C, Perez-Perez A, Gonzalez-Yanes C & Sanchez-Margalet V. 2010 Role of leptin in the activation of immune cells. Mediators of Inflammation. 2010 568343
12. Funicello M, Novelli M, Ragni M, Vottari T, Cocuzza C, Soriano-Lopez J, Chiellini C, Boschi F, Marzola P, Masiello P et al.. 2007 Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores. PLoS ONE 2 e683
13. Grasso P, Leinung MC, Ingher SP & Lee DW. 1997 In vivo effects of leptin-related synthetic peptides on body weight and food intake in female ob/ob mice: localization of leptin activity to domains between amino acid residues 106-140. Endocrinology 138 1413-1418
14. Gruen ML, Hao M, Piston DW & Hasty AH. 2007 Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. American Journal of Physiology. Cell Physiology 293 C1481-C1488
15. Haynes WG. 2005 Role of leptin in obesity-related hypertension. Experimental Physiology 90 683-688
16. Honey K & Rudensky AY 2003 Lysosomal cysteine proteases regulate antigen presentation. Nature Reviews. Immunology 3 472-482
17. Huang L, Wang Z & Li C. 2001 Modulation of circulating leptin levels by its soluble receptor. Journal of Biological Chemistry 276 6343-6349.
18. Jobs E, Riserus U, Ingelsson E, Helmersson J, Nerpin E, Jobs M, Sundstrom J, Lind L, Larsson A, Basu S et al.. 2010 Serum cathepsin S is associated with serum C-reactive protein and interleukin-6 independently of obesity in elderly men. Journal of Clinical Endocrinology and Metabolism 95 4460-4464.
19. Kirschke H, Wiederanders B, Bromme D & Rinne A. 1989 Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochemical Journal 264 467-473.
20. Lafarge JC, Naour N, Clement K & Guerre-Millo M. 2010 Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 92 1580-1586.
21. Lago F, Dieguez C, Gomez-Reino J & Gualillo O. 2007 Adipokines as emerging mediators of immune response and inflammation. Nature Clinical Practice. Rheumatology 3 716-724
22. Lammert A, Kiess W, Bottner A, Glasow A & Kratzsch J. 2001 Soluble leptin receptor represents the main leptin binding activity in human blood. Biochemical and Biophysical Research Communications 283 982-988.
23. Lee MJ & Fried SK. 2006 Multilevel regulation of leptin storage, turnover, and secretion by feeding and insulin in rat adipose tissue. Journal of Lipid Research 47. 1984-1993
24. Linnevers CJ, McGrath ME, Armstrong R, Mistry FR, Barnes MG, Klaus JL, Palmer JT, Katz BA & Bromme D. 1997 Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex. Protein Science 6 919-921
25. Lutzner N & Kalbacher H. 2008 Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate. Journal of Biological Chemistry 283 36185-36194
26. Martins MN, Telles MM, Zemdegs JC, Andrade IS, Ribeiro EB &Miranda A. 2009 Evaluation of new leptin fragments on food intake and body weight of normal rats. Regulatory Peptides 153 77-82
27. Mohamed MM & Sloane BF. 2006 Cysteine cathepsins: multifunctional enzymes in cancer. Nature Reviews. Cancer 6 764-775
28. Naour N, Rouault C, Fellahi S, Lavoie ME, Poitou C, Keophiphath M, Eberle D, Shoelson S, Rizkalla S, Bastard JP et al.. 2010 Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin s in adipose tissue and in circulation. Journal of Clinical Endocrinology and Metabolism 95 1861-1868
29. Oliveira VXD Jr, Fázio MA, Santos EL, Pesquero JB & Miranda A. 2008 In vitro evaluation of leptin fragments activity on the ob receptor. Journal of Peptide Science 14 617-625
30. Oliveira M, Torquato RJ, Alves MF, Juliano MA, Bromme D, Barros NM & Carmona AK. 2010 Improvement of cathepsin S detection using a designed FRET peptide based on putative natural substrates. Peptides 31 562-567.
31. Paschoalin T, Carmona AK, Rodrigues EG, Oliveira V, Monteiro HP, Juliano MA, Juliano L & Travassos LR. 2007 Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth. Molecular Cancer 6 44
32. Rau H, Reaves BJ, O'Rahilly S & Whitehead JP. 1999 Truncated human leptin (delta133) associated with extreme obesity undergoes proteasomal degradation after defective intracellular transport. Endocrinology 140 1718-1723
33. Sahu A. 2004 Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 145 2613-2620.
34. Samson WK, Murphy TC, Robison D, Vargas T, Tau E & Chang JK. 1996 A 35 amino acid fragment of leptin inhibits feeding in the rat. Endocrinology 137 5182-5185
35. Santos-Alvarez J, Goberna R & Sanchez-Margalet V. 1999 Human leptin stimulates proliferation and activation of human circulating monocytes. Cellular Immunology. 194 6-11
36. Shi GP, Munger JS, Meara JP, Rich DH & Chapman HA. 1992 Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. Journal of Biological Chemistry 267 7258-7262.
37. Stamatiadis DN, Chan JL, Cogswell R, Stefanopoulou HC, Bullen J, Katsilambros N, Stathakis CP & Mantzoros CS. 2004 Elevated leptin fragments in renal failure correlate with BMI and haematopoiesis and are normalized by haemodialysis. Clinical Endocrinology 60 434-441.
38. Suganami T & Ogawa Y. 2010 Adipose tissue macrophages: their role in adipose tissue remodeling. Journal of Leukocyte Biology 88 33-39.
39. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML et al.. 2003 Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. Journal of Clinical Investigation 111 897-906
40. Sweeney G. 2010 Cardiovascular effects of leptin. Nature Reviews. Cardiology 7 22-29
41. Taleb S, Lacasa D, Bastard JP, Poitou C, Cancello R, Pelloux V, Viguerie N, Benis A, Zucker JD, Bouillot JL et al.. 2005 Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB Journal. 19 1540-1542.
42. Taleb S, Cancello R, Clement K & Lacasa D. 2006a Cathepsin S promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 147 4950-4959
43. Taleb S, Cancello R, Poitou C, Rouault C, Sellam P, Levy P, Bouillot JL, Coussieu C, Basdevant A, Guerre-Millo M et al.. 2006b Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women. Journal of Clinical Endocrinology and Metabolism 91 1042-1047.
44. Taleb S, Herbin O, Ait-Oufella H,Verreth W, Gourdy P, Barateau V, Merval R, Esposito B, Clement K, Holvoet P et al.. 2007 Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protectsmice from atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 27 2691-2698.
45. Tartaglia LA. 1997 The leptin receptor. Journal of Biological Chemistry 272 6093-6096.
46. Telles MM, Guimaraes RB & Ribeiro EB. 2003 Effect of leptin on the acute feeding-induced hypothalamic serotonergic stimulation in normal rats. Regulatory Peptides 115 11-18
47. Thomas AD, Murray JD & Oberbauer AM. 2004 Leptin modulates fertility under the influence of elevated growth hormone as modeled in oMt1a-oGH transgenic mice. Journal of Endocrinology 182 421-432
48. Turk D & Guncar G. 2003 Lysosomal cysteine proteases (cathepsins): promising drug targets. Acta Crystallographica. Section D. Biological Crystallography 59. 203-213
49. Turk B, Turk D & Turk V. 2000 Lysosomal cysteine proteases: more than scavengers. Biochimica et Biophysica Acta 1477 98-111
50. Turk V, Turk B & Turk D. 2001 Lysosomal cysteine proteases: facts and opportunities. EMBO Journal. 20 4629-4633
51. Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B & Turk D. 2012 Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochemica et Biophysica Acta 1824 68-88.
52. Uotani S, Bjørbaek C, Tornøe J & Flier JS. 1999 Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligandinduced receptor downregulation. Diabetes 48 279-286
53. Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V & Turk B. 2007 Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Current Pharmaceutical Design 13 387-403
54. Yang M, Zhang Y, Pan J, Sun J, Liu J, Libby P, Sukhova GK, Doria A, Katunuma N, Peroni OD et al.. 2007 Cathepsin L activity controls adipogenesis and glucose tolerance. Nature Cell Biology 9 970-977.
55. Yang M,Sun J,Zhang T, Liu J,Zhang J, ShiMA, Darakhshan F,Guerre-Millo M, Clement K, Gelb BD et al.. 2008 Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arteriosclerosis, Thrombosis, and Vascular Biology 28 2202-2208.
56. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM. 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372 425-432